Analysts expect Co-Diagnostics, Inc. to report revenue of 176,081.10 for Q3 26, against a range of 167,626.04 to 184,536.16. The most recent reported quarter, Q2 26, came in at 166,130.00, a 20.3% beat against the 138,107.26 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 641,140.00 | 149,320.00 | 50,280.00 | 162,910.00 | 145,380.00 | 262,490.00 | 145,950.00 | 166,130.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 369,751.95 | 397,475.12 | 228,080.27 | 336,254.96 | 332,552.19 | 142,813.58 | 138,257.92 | 147,430.33 | 184,536.16 | 178,307.60 | 10.27 M | 11.00 M | 4.68 M | 2.29 M | 15.60 M | 27.94 M | ||||||||||
| Low Estimate | 347,116.81 | 329,653.64 | 189,523.73 | 296,349.04 | 287,265.81 | 119,699.08 | 126,323.70 | 128,784.19 | 167,626.04 | 159,130.64 | 9.66 M | 9.37 M | 4.15 M | 2.00 M | 12.87 M | 24.02 M | ||||||||||
| Consensus Estimate | 358,434.38 | 363,564.38 | 208,802.00 | 316,302.00 | 309,909.00 | 131,256.33 | 132,290.81 | 138,107.26 | 176,081.10 | 168,719.12 | 9.96 M | 10.18 M | 4.42 M | 2.15 M | 14.23 M | 25.98 M |
Analysts expect Co-Diagnostics, Inc. to report earnings per share of -1.33 for Q3 26, against a range of -1.39 to -1.27. The most recent reported quarter, Q2 26, came in at -1.46, a 50.2% beat against the -2.93 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -9.60 | -10.80 | -7.20 | -6.90 | -4.80 | -16.35 | -4.06 | -1.46 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -9.58 | -9.22 | -8.11 | -6.87 | -5.10 | -3.44 | -3.58 | -2.65 | -1.27 | -0.25 | -0.74 | -0.78 | 0.46 | -0.22 | 0.63 | -0.19 | ||||||||||
| Low Estimate | -11.00 | -10.52 | -8.85 | -7.43 | -5.54 | -3.96 | -4.36 | -3.21 | -1.39 | -0.27 | -0.90 | -0.88 | 0.42 | -0.24 | 0.53 | -0.23 | ||||||||||
| Consensus Estimate | -10.29 | -9.87 | -8.48 | -7.15 | -5.32 | -3.70 | -3.97 | -2.93 | -1.33 | -0.26 | -0.82 | -0.83 | 0.44 | -0.23 | 0.58 | -0.21 |
Pull Wall Street consensus for Co-Diagnostics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CODX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CODX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CODX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();